Fusion protein technologies for biopharmaceuticals applications and challenges /

Fusion protein technologies for biopharmaceuticals applications and challenges /

Show other versions (1)
Saved in:
Bibliographic Details
Corporate Author: ebrary, Inc
Other Authors: Schmidt, Stefan R.
Format: Electronic eBook
Language:English
Published: Hoboken, N.J. : J. Wiley & Sons, c2013.
Subjects:
Recombinant proteins.
Biopharmaceutics.
Electronic books.
Online Access:An electronic book accessible through the World Wide Web; click to view
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 a 4500
001 0000164654
005 20171002063221.0
006 m u
007 cr cn|||||||||
008 121002s2013 njua sb 001 0 eng d
010 |z  2012039440 
020 |z 9781118354575 (e-book) 
035 |a (CaPaEBR)ebr10662566 
035 |a (OCoLC)811850420 
040 |a CaPaEBR  |c CaPaEBR 
050 1 4 |a TP248.65.P76  |b F87 2013eb 
082 0 4 |a 615.7  |2 23 
245 0 0 |a Fusion protein technologies for biopharmaceuticals  |h [electronic resource] :  |b applications and challenges /  |c edited by Stefan R. Schmidt. 
260 |a Hoboken, N.J. :  |b J. Wiley & Sons,  |c c2013. 
300 |a xxviii, 624 p. :  |b ill. 
504 |a Includes bibliographical references and index. 
505 0 |a pt. 1. Introduction -- pt. 2. The triple t paradigm : time, toxin, targeting -- pt. 3. Beyond the triple t-paradigm. 
533 |a Electronic reproduction.  |b Palo Alto, Calif. :  |c ebrary,  |d 2013.  |n Available via World Wide Web.  |n Access may be limited to ebrary affiliated libraries. 
588 |a Description based on print version record and CIP data provided by publisher; resource not viewed. 
650 0 |a Recombinant proteins. 
650 0 |a Biopharmaceutics. 
655 7 |a Electronic books.  |2 local 
700 1 |a Schmidt, Stefan R. 
710 2 |a ebrary, Inc. 
856 4 0 |u http://site.ebrary.com/lib/daystar/Doc?id=10662566  |z An electronic book accessible through the World Wide Web; click to view 
908 |a 170314 
942 0 0 |c EB 
999 |c 153800  |d 153800 

Similar Items